Dr. Ramon Gonzalez, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 244 Village Pond Rd, Guilford, CT 06437 Phone: 203-453-1338 |
Dr. Michael S Kelleher Jr., M.D. Radiology - Pediatric Radiology Medicare: Accepting Medicare Assignments Practice Location: 1591 Boston Post Rd Ste 106, Guilford, CT 06437 Phone: 203-453-5123 |
Dr. William N Friedman, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 111 Goose Ln, Guilford, CT 06437 Phone: 203-453-7200 |
News Archive
A number of U.S. cities have installed acoustic gunshot sensor technology to accurately locate shooting scenes and potential gunshot victims, but the effectiveness of this technology for saving lives had not been studied until surgeons at the University of California, San Francisco-East Bay in Oakland, Calif., found that this sensor technology may benefit shooting victims by helping them get to the emergency room sooner than they may have otherwise.
University Hospitals Case Medical Center is among the first in the country - and the first in Ohio - to offer and deploy the Abbott Absorb stent, a completely bioresorbable stent. The Absorb stent works exactly as its traditional metallic predecessors in that it opens a blocked coronary artery, with one major exception - it dissolves completely in the body two to three years after implantation.
BiondVax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases,today announced that it has been invited to present in a workshop organized by EDUFULVAC, (EDUcate inFLUenza VACcine) a corresponding European Consortium coordinated by the European Vaccine Initiative (Germany) and NIAID (the National Instituteof Allergy and Infectious Diseases, a National Institute of Health branch) in the United States.
Edwards Lifesciences Corporation, a world leader in products and technologies to treat advanced cardiovascular disease, today reported net income for the quarter ended September 30, 2009 of $73.5 million, or $1.25 per diluted share, compared to net income of $32.9 million, or $0.56 per diluted share, for the same period in 2008.
› Verified 6 days ago